choose language

Deutsch Français 日本語 简体中文

ECG Monitor used with Move ECG has received CE marking following the Medical Device Directive 93/42/EEC as amended by the 2007/47/EC.

The multicentric study took place at Centre Cardiologique du Nord (Saint-Denis, France) and Aixum Clinic (Aix-en-Provence, France).

The ability of Move ECG to accurately classify an ECG recording into AFib and sinus rhythm was validated in a clinical trial of 137 participants. Rhythm classification from a gold standard 12-lead ECG read by a cardiac electrophysiologist was compared to the rhythm classification of an ECG collected from the Move ECG.

The performance of ECG Monitor is measured in terms of the sensitivity to detect AFib and the specificity to detect a normal sinus rhythm:

  • 54 patients were in Normal Sinus Rhythm according to the reference. ECG Monitor correctly identified 53 of them, giving a specificity of Sp = 98.1%. 
  • 57 patients were in AFib according to the reference, and ECG Monitor correctly classified 56 of them, giving a sensitivity of Se = 98.2%.
Was this article helpful?

Didn't find what you need? Here's how to get in touch.

Contact us
To preserve the Withings Forum as a place of kindness, mutual support, and interest for the products and services provided by Withings, I am committed to:
  • Be courteous and participate in the community with a spirit of friendliness and understanding
  • Respect all users on the forum
  • Avoid controversy or quarrel
  • Ensure that my messages do not infringe on the rights, reputation, image, or privacy of others
  • Avoid any and all discussions which contain insulting or discriminatory comments
  • Abide by the full terms and conditions outlined here

Note that this community is supported by its members, not the Withings Support Team.

If you need assistance because of an issue which would not be resolved through troubleshooting, such as a product with physical damage, please contact our Support Team.